Medical Marijuana Stocks « AGORACOM Small-cap Investor Relations Blog

Archive for the ‘Medical Marijuana Stocks’ Category

Lexaria Closes First Tranche of Financing

Posted by AGORACOM-JC at 4:20 PM on Tuesday, August 12th, 2014

Kelowna, British Columbia–(August 12, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it has closed the first tranche of its Private Placement financing announced on August 9 for gross proceeds of $187,700.

Lexaria will issue 1,251,333 common shares at US$0.15 and 1,251,333 full warrants that expire on February 12, 2016 with an exercise price of US$0.25. The Company may accelerate the expiry date of the warrants if the stock price trades above CAD$0.60 cents for 20 consecutive days at any time after 6 months and one day has elapsed.

Finders’ fees of 51,000 broker’s warrants of the Company were issued, and cash finders’ fees of $7,650 were paid to various brokers.

Further announcements regarding a subsequent tranche closing, and of developments in the medical marijuana sector, will be made as information becomes available.

All issued shares will be subject to a hold period, for any resale into the USA under Rule 144, of six months and one day. Proceeds of the Private Placement will be used for general working capital, for general and administrative needs, and for corporate opportunities in the medical marijuana sector. The Private Placement is subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Closes First Tranche of Financing

Harry Barr, Medical Marijuana Business Visionary Featured on CEO Interview

Posted by AGORACOM-JC at 3:37 PM on Tuesday, August 12th, 2014

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen Metals Inc. is a diversified public company which focuses on the Medical Marijuana and Industrial Hemp industries in North America. Next Gen also has a Mineral Exploration division.

Since March 2014, NextGen has established two 100% owned Subsidiaries ( GreenRush Financial Conferences and GreenRush Analytical Laboratories) and a new Business Unit (GreenRush Business Brokerage)

GreenRush Financial Conferences held in Vancouver and Toronto exceeded expectations and continues to establish the GreenRush Financial Conference as the premier investment/business conferences in the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

Third conference will be September 23, 2014, in Seattle, Washington

GreenRush Analytical Laboratories’ management has been working with financial and technical advisors to formulate, consider and propose strategic options that would be in the best interests of NextGen’s Shareholders

GreenRush Analytical Laboratories’ management is in the process of assessing and selecting initial locations to establish first laboratory facility and have visited and evaluated different locations.

GreenRush Business Brokerage, when fully operational, will provide business to business brokerage services, Business and analytical valuations, consulting, confidential marketing and assistance from initial due diligence to completion of the final transaction.

Click image below

Hub On AGORACOM / Watch Interview Now!

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, GreenRush Conferences, GreenRush Financial Conferences, medical Marijuana
Posted in AGORACOM Via Satellite, All Recent Posts, Medical Marijuana Stocks, Next Gen | Comments Off on Harry Barr, Medical Marijuana Business Visionary Featured on CEO Interview

Lexaria Intends to Complete a $900,000 Financing

Posted by AGORACOM-JC at 9:12 AM on Friday, August 8th, 2014

Kelowna, British Columbia–(August 8, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) reports its intention to complete a non-brokered private placement financing, consisting of 6,000,000 Equity Units at US $0.15 per unit, to raise gross proceeds of up to US $900,000 (the “Private Placement”).

Each equity unit will consist of one common share of the Company and one non-transferable share purchase warrant, each warrant entitling the holder to purchase one additional common share of the Company for a period of eighteen months from the date of issuance, at a purchase price of US$0.25. The Company may accelerate the expiry date of the warrants if the stock price trades above CAD$0.60 for 20 consecutive days at any time after 6 months and one day has elapsed.

Lexaria may pay broker commissions of up to 6.0% in cash and 6% in broker warrants in connection with the Private Placement. Each broker’s warrant will be exercisable into one single common share (a “Warrant Share”) at a price of US$0.25 per Warrant Share for a period of eighteen (18) months following closing of the Offering. Certain directors, officers and insiders of the Company may participate in the Private Placement.

The Company is canceling its earlier announced intention to complete a non-brokered private placement financing, consisting of 17,000,000 Equity Units at US $0.20 per unit, to raise gross proceeds of up to US $3,400,000 (the “Private Placement”) due to market conditions and the increased dilution the larger proposed financing would have caused.

The securities issued will be subject to a hold period in Canada of four months and one day, or for any resales possible into the USA under Rule 144, six months and one day. Proceeds from the equity units will be used for corporate development in the Medical Marijuana business, G&A and general working capital. The Private Placement will be subject to normal regulatory approvals.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Manager: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria and no assurance that the proposed financing of up to $900,000 will be successful.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Intends to Complete a $900,000 Financing

Next Gen Provides Corporate Update

Posted by AGORACOM-JC at 8:38 AM on Wednesday, August 6th, 2014

-Since March 2014, NextGen has established two 100% owned Subsidiaries ( GreenRush Financial Conferences and GreenRush Analytical Laboratories) and a new Business Unit (GreenRush Business Brokerage)

-GreenRush Financial Conferences held in Vancouver and Toronto exceeded expectations and continues to establish the GreenRush Financial Conference as the premier investment/business conferences in the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries

-Our third conference will be September 23, 2014, in Seattle, Washington

-GreenRush Analytical Laboratories’ management has been working with financial and technical advisors to formulate, consider and propose strategic options that would be in the best interests of NextGen’s Shareholders

-GreenRush Analytical Laboratories’ management is in the process of assessing and selecting initial locations to establish first laboratory facility and have visited and evaluated different locations.

-GreenRush Business Brokerage, when fully operational, will provide business to business brokerage services, Business and analytical valuations, consulting, confidential marketing and assistance from initial due diligence to completion of the final transaction.

-Next Gen’s Management continues to aggressively identify and acquire new businesses within our Industries

Vancouver, British Columbia, Canada TNW-ACCESSWIRE / August 6 2014 / Next Gen Metals Inc. (“Next Gen”, the “Company”) (CSE: N, OTC Pink: NXTTF, FSE: M5BN) is pleased to announce an update on the rapid development of the Company and its activities.

Since February 26th, 2014 that Next Gen Metals announced its plan to diversify into Medical Marijuana, Industrial Hemp and Alternative Medicine space; the company has established two wholly owned subsidiaries, GreenRush Financial Conferences and GreenRush Analytical Laboratories’. On June 23rd, the company announced a new Business unit, GreenRush Business Brokerage, due to enormous amount of businesses that require capital and management expertise within our chosen industries.

Our company has gone through a tremendous expansion in the last five months and outside of our new businesses, we have also added a number of key technical and financial advisors. The Company’s seasoned advisors with their significant experience in the above industries will further strengthen our new businesses.

Update on GreenRush Financial Conferences:

GreenRush Financial Conferences’ vision is to be the premier purveyor of educational and investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries. Each conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, media and retail investors who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

GreenRush Conferences are tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Our first GreenRush Financial Conference held on May 7th, 2014 in Vancouver, British Columbia exceeded our expectations. Over 1,500 fund managers, bankers, brokers, analysts, retail investors, interested industry followers and media attended the conference. Over 40 companies exhibited the conference and 28 expert speakers from across North America presented their companies or visions. The conference was covered by major media outlets across Canada the U.S and Europe.

Our Second GreenRush Financial Conference held in Toronto, Ontario also exceeded expectations with over 1200 attendees, over 37 exhibitors and 31 speakers, continues to establish the GreenRush Financial Conferences as the premier investment/business conference in the Industry.

Next Gen also formally invites interested investors, industry participants, stakeholders and exhibitors to our third GreenRush Financial Conference being held in Seattle, Washington in September 2014. We plan to announce our Fall 2014, Winter/Spring 2015 Program within the next 60 days

Companies seeking financing for their projects (business to business) will utilize the GreenRush Financial Conferences as their platform to educate Institutional Investors, Financial Advisors, Accredited and Retail Investors and the general public about their projects, their companies, potential sales from their product lines and related business plans.

Click Image To View Full Size

We have now set the stage for future conferences. Our next conferences are slated for the Seattle, Washington-fall 2014 and additional conferences would be held in Calgary, Edmonton, Montreal, other U.S cities and Europe in 2014-2015.

Update on GreenRush Analytical Laboratories:

GreenRush Analytical Laboratories’ management has been working with financial and technical advisors to formulate, consider, and propose strategic options that would be in the best interests of Next Gen’s Shareholders with respect to its wholly owned subsidiary, GAL. As part of this process, meetings have been held with several consultants, government authorities and advisors to identify and consider financing and technical solutions that would work best for Next Gen’s stakeholders. We are also in the process of assessing and selecting initial locations and jurisdictions to establish our laboratories. To that end we have visited and evaluated several different locations in British Columbia and Ontario.

A consult company that specializes in the laboratory setup has also been contracted to help establish GreenRush analytical laboratories

GreenRush Laboratories (GAL) is Next Gen’s fully owned subsidiary providing Analytical Analysis for medical-grade cannabis products. GAL will seek to become a certified Analytical Laboratory under the new Marijuana for Medical Purposes Regulations (MMPR) and will establish analytical laboratories equipped to provide product analysis and micro propagation and other professional services to Licensed Producers, distributers, caregivers and Industrial Hemp farmers. Our goal is to provide analytical testing to the cannabis industry to ensure the health and safety of consumers and to maximize the quality of our client’s products.

GreenRush Business Brokerage:

On June 23rd, Next Gen announced that it has established its wholly owned Business unit, GreenRush Business Brokerage (GBB). GreenRush Business Brokerage (GBB) is a business brokerage and advisory and consultancy business unit of Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN).

The Mission of GreenRush Business Brokerage is to broker our growing business inventory utilizing a standard agreement finder’s fee with businesses that require finance to interested parties who can provide Professional Management, Investment Expertise and Venture Capital for the Medical Marijuana, Industrial Hemp and Alternative Medicine business sectors.

GreenRush Business Brokerage (GBB), when fully operational, will provide business to business brokerage services, Business and analytical valuations, consulting, confidential marketing and assistance from initial due diligence to completion of the final transaction.

At GreenRush Business Brokerage (GBB) we constantly solicit and investigate Business Plans and Proposals for the Medical Marijuana, Industrial Hemp and Alternative medicine industries. Management and our corporate advisors are experts in analyzing trends, developments and policies in the above industries.

Our combined management team has over 300 years of experience in managing public and private companies, negotiating complex deals and raising venture capital. We plan to add this expertise to our GreenRush Business Brokerage unit.

About Next Gen

(CSE: N, OTC Pink: NXTTF, FSE: M5BN)

Next Gen is a diversified Canadian public company which focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. Recent regulatory/legal changes in North America have provided an opportunity for the company to enter into this emerging multi-billion dollar industry. Next Gen’s vision is to be the leading provider of venture capital, management expertise, education, brokerage and consultancy solutions and a facilitator for these explosive new industries.

Next Gen’s business model generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangements to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industries. For further information on the company, visit our website at www.Next Genmetalsinc.com .

On March 20, 2014 Next Gen Metals announced that it had established its first wholly owned subsidiary, a Conference Division that intends to host Canada’s first conferences focused on business to business opportunities, the investment and education in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Financial Conferences’ vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries. After two very successful conferences in Canada, management has selected Seattle Washington for its third conference. Seattle was selected due to recent changes in Washington’s laws (see Company’s last press release for more information on why Seattle and why US conferences).

If you are interested in being a speaker, exhibitor or sponsor for future Financial Conferences please submit your indication of specific interest as soon as possible to the GreenRush Financial Conference team as the available spaces are fill up quickly.

On May 6, 2014 Next Gen announced the establishment of its second wholly owned subsidiary GreenRush Analytical Laboratories Inc. GreenRush Analytical Laboratories Inc. will provide analytical testing to the cannabis industry by delivering customized solutions and accurate analytical results and ensure the health and safety of consumers. GreenRush Analytical Laboratories vision is to become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.

Next Gen’s Management’s intention is to invest in a basket of companies within these growing industries. The company’s business model continues to generate new business plans and project submittals 24/7. In light of Next Gen’s vision, Management is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, Brokerage and Consultancy Solutions, Public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Click Image To View Full Size

For more information on GreenRush Conferences please visit our website at www.greenrushfinancialconferences.com, email us at info@Next Genmetalsinc.com or contact us by phone at (604) 685-1870.
About GreenRush Financial Conferences

Click Image To View Full Size

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (Public Company, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of educational and investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

We would also like to invite the participants, attendees, keynote speakers, industry and investment experts all to attend to our next conferences which are slated for the Seattle, Washington-Fall 2014 with additional conferences in Calgary, Edmonton, Montreal, other US cities and Europe in 2014-2015.

About GreenRush Analytical Laboratories Inc.:

GreenRush Laboratories (GAL) is Next Gen’s fully owned subsidiary providing Analytical Analysis for medical-grade cannabis products.

GAL will seek to become a certified Analytical Laboratory under the new Marijuana for Medical Purposes Regulations (MMPR) and will establish analytical laboratories equipped to provide product analysis and micro propagation and other professional services to Licensed Producers, distributers, caregivers and Industrial Hemp farmers.

Our goal is to provide analytical testing to the cannabis industry to ensure the health and safety of consumers and to maximize the quality of our client’s products.

Initial locations are being finalized in British Colombia and Ontario

For further information on GreenRush Analytical Laboratories Inc. please visit us at http://www.greenrushanalyticallabs.com/

About GreenRush Business Brokerage

GreenRush Business Brokerage (GBB) is a business brokerage and advisory and consultancy business unit of Next Gen (CSE: N, OTC Pink: NXTTF, FSE: M5BN), GBB is headquartered in Vancouver, British Columbia with satellite offices in Toronto and Rockport, Ontario, and Maui county, Hawaii, USA. GreenRush Business Brokerage unit serves as an intermediary between buyers and sellers of small to medium-size businesses across the Medical Marijuana, Industrial Hemp and Alternative medicine industries.

For further information on GreenRush Business Brokerage Unit please visit us at www.Next Genmetalsinc.com

On behalf of the Board of Directors

“Harry Barr”

Harry Barr

President & CEO

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This News Release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this News Release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on Next Gen Provides Corporate Update

Lexaria Announces Corporate Update

Posted by AGORACOM-JC at 8:31 AM on Tuesday, August 5th, 2014

Kelowna, British Columbia–(August 5, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is announces that it is in the process of making all the cash and stock payments required to secure its lease of the Burlington marijuana production facility to Dec 9, 2014. This includes the issuance of 91,662 restricted common shares to the building owner as Lexaria’s portion of the lease costs.

As earlier announced, the Burlington joint venture with Enertopia Corp has received municipal approval. The Lexaria/Enertopia joint venture is for a building of approx 75,000 sq ft in total potential space available. Additional lease payments will be required after Dec 9, 2014. Progress on the joint venture continues to be made and Lexaria will report new developments soon, as they are finalized.

Separately, the Company has issued 82,031 restricted common shares to Agora Internet Relations Corp, for a quarterly payment as per an agreement originally announced in March, 2014.

Although the share issuances disclosed herein are not large, Lexaria has a policy of informing investors on every occasion when shares are issued, as changes to the Company’s capital structure are material events. It is important that shareholders have the most current information possible, and this is part of Lexaria’s continuous efforts at full transparency. After these shares are issued, Lexaria will have 32,998,357 shares issued and outstanding.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp. Chris Bunka, CEO: (250) 765-6424
Clark Kent, Media Inquiries: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that any municipality where proposed facilities are located will retain its approval for a medical marijuana production facility. The Company is not currently growing or selling medical marijuana.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Announces Corporate Update

Enertopia Provides Corporate Update

Posted by AGORACOM-JC at 8:07 AM on Tuesday, August 5th, 2014

VANCOUVER, BC /August 5, 2014 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announces the following corporate update.

With the recent success of the Burlington municipal approval the Company is pleased to announce it has issued 118,416 shares to 1475714 Ontario Inc. as required under the building lease agreement for its base share of lease costs for the remainder of 2014 under the Lease agreement. The Company and its JV partner Lexaria Corp will have a project update in the coming weeks.

The Company is currently reviewing opportunities in the oil & edibles, and industrial hemp markets across North America, as it looks to broaden its opportunities for multiple streams of revenue.

The Company has also engaged Neil Blake to help out with our Investors Relations outreach.

The Enertopia website has been updated to reflect the company’s growing focus on patient well being as the investment community grows in its understanding of the importance of Medical marijuana and the importance of natural CBD medication, please visit www.enertopia.com

Follow Enertopia:

Twitter: www.twitter.com/EnertopiaCorp

Facebook: www.Facebook.com/EnertopiaCorp

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Burlington JV will obtain a license under MMPR and or that the Company will be able to obtain future financings. Similarly, there can be no assurance that the Company will be successful in securing operations in the oils, edibles or hemp markets.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Provides Corporate Update

Parents of six-year-old medical marijuana user calling for legal access to marijuana oil

Posted by AGORACOM-JC at 10:11 AM on Tuesday, July 29th, 2014

CTV Ottawa

The parents of six-year-old Ottawa Constance Bay boy who suffers from a rare form of epilepsy are desperately calling for changes to Canada’s medicinal marijuana laws.

Liam McKnight’s parents are breaking the rule by giving him marijuana oil to help treat his severe seizures.

Liam has Dravet Syndrome, a rare form of epilepsy that causes him to suffer violent seizures, sometimes dozens a day.

But under Heath Canada rules, licensed producers can only produce and distribute dried marijuana.

Liamâ€™s mother Mandy McKnight says her son is technically only allowed to smoke it or vaporize it.

But she doesnâ€™t want Liam smoking marijuana, and she says he wouldnâ€™t be able to anyway.

Liam is developmentally delayed, and his mother says he would not understand how to inhale it.

McKnight says the best way for Liam to receive the medical benifits of the drug is to ingest it as an oil, not to smoke it.

The strain of marijuana Liam is taking is higher in CBD, the compound that helps him, and very low in THC, the compound that produces the drug’s “high” effects.

Liam’s mom says they have tried several different medications to treat Liamâ€™s seizures, and so far marijuana oil has been their best defence against them.

Liamâ€™s parents are calling on the federal government to make medicinal marijuana oil legal.

Right now, they must go through the costly and lengthy process of buying the dried marijuana, having it converted into oil, then tested to check its properties so they can determine the proper dosage to give Liam.

They say they donâ€™t know how long they can sustain that.

According to Health Canada, â€œcurrent regulations for clinical trials would allow a sponsor to propose a clinical trial for extracts of cannabis. A manufacturer or another sponsor (e.g., a physician or treatment centre) can submit a clinical trial application to Health Canada at any time.â€

But the McNights say they donâ€™t have time to wait for a clinical trial.

They say last year, 14 children in their Dravet Syndrome support group passed away.

They want Liam to have easier access to the oil so his quality of life can be improved.
â€œI donâ€™t understand why Health Canada is preventing him from accessing a medication that could potentially save his life, or extend it for a very long period of time,â€ Mandy McKnight said.

â€œWeâ€™re trying to do everything we can to just give him a break, and give him a chance to just be a kid,â€ she said. â€œI think itâ€™s a viable treatment option, and he deserves a chance to try it.â€

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana, otcqb
Posted in Enertopia, Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Parents of six-year-old medical marijuana user calling for legal access to marijuana oil

Enertopia Announces AGM Results

Posted by AGORACOM-JC at 8:06 AM on Wednesday, July 23rd, 2014

Vancouver, BC /July 23 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce all resolutions were approved and adopted at its Annual General Meeting (AGM) held on July 15th.

Re-election of directors was approved with the following results:

Nominee	For	Withhold	Not Voted
Robert McAllister	18,929,105 (99.41%)	113,264 (0.59%)	11,529,448
Donald Findlay	18,963,169 (99.58%)	79,200 (0.42%)	11,529,448
John Thomas	19,000,854 (99.78%)	41,515 (0.22%)	11,529,448
Mathew Chadwick	2,084,772 (10.95%)	16,957,597 (89.05%)	11,529,448

-Ratification of MNP LLP our independent registered public accounting firm to hold office until the close of the next annual general meeting and to allow directors to set the remuneration, approved with 30,286,680 votes For (99.07%), 285,136 votes Against (0.93%) and 1 vote Not Voted; and

-Ratification of the change of business to the regulated marijuana industry was passed with 19,029,444 votes For (99.93%), 12,925 votes Against (0.07%), and 11,529,448 Not Voted; and

-Shareholders approved the compensation of our company’s named executive officers (Say-On-Pay), by a vote of 19,008,019 votes For (99.82%), 34,350 votes Against (0.18%), and 11,554,370 Not Voted; and

-Shareholders approved a 3-year frequency (Say-When-On-Pay) of future advisory votes on the compensation of our company’s named executive officers, by the following votes One Year – 1,452,183, Two Years – 74,858 Three Years – 17,490,406, Not Voted – 11,554,370; and

-Ratification of the Company’s 2014 stock option plan was passed with 18,996,969 votes For (99.76%), 45,400 votes Against (0.24%), and 11,529,448 Not Voted.

The Company also notes that 252,000 warrants have been exercised raising $25,200 in net proceeds.

About Enertopia

Enertopia’s shares are quoted in the USA with symbol ENRT and in Canada with symbol TOP.

To learn more about Enertopia Corp. visit www.enertopia.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Ken Faulkner, Business and Institutional Development: (250) 765-3630

Clark Kent, Media Inquiries: (647) 519-2646

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces AGM Results

InvestmentPitch Media Attending Next Gen Metal’s GreenRush Financial Conference in Seattle, Washington on September 23, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines

Posted by AGORACOM-JC at 6:32 PM on Tuesday, July 22nd, 2014

Vancouver, British Columbia–(July 22, 2014) – InvestmentPitch Media will be attending the upcoming GreenRush Financial Conference in Seattle, Washington. Following very successful GreenRush Financial Conferences in Vancouver in May, and Toronto in June, arrangements are in place for the next conference which will be held on September 23rd at the Washington State Convention Centre, from 7:00 am to 5:00 pm.

For more details, please watch this video. If this link is not enabled, please visit www.InvestmentPitch.com and enter â€œGreenRush Conferenceâ€ in the search box. InvestmentPitch is a media partner for this event, and will be available to film presentations and conduct interviews.

http://www.investmentpitch.com/video/0_wjudlxo5/InvestmentPitch-Media-Invite–GreenRush-Financial-Conference-in-Seattle-Washington–Sept-23-2014

Harry Barr, CEO, stated: “We are pleased with the results of the first two Canadian GreenRush Financial Conferences and look forward to exporting our success and brand to the United States. We would like to thank the 40+ exhibitors, 1200+ attendees and expert speakers from around the world that came together to make this Toronto conference the success that it was. We look forward to hosting our third GreenRush Financial Conference in Seattle, Washington which is the newest state to legalize recreational marijuana. Given the size of the US market, its population when compared to Canada and the fact that marijuana is legal both recreationally and medically in Washington State we anticipate that our third conference will be even bigger and better received than our conferences have been to date.”

The conference will provide a platform for venture capital investment, education and business to business opportunities, with exhibitors having a forum to showcase their products, technologies and services. For further information or to register as an attendee for the Seattle Conference, please visit www.greenrushfinancialconferences.com.

For information about further conferences, which are also being considered for North and South America as well as Europe and the Caribbean, please register on their site.

If you are interested in being a speaker, exhibitor or sponsor for the Seattle Conference please contact the GreenRush Financial Conference team at 604-685-1870 or 1-800-667-1870 or email the following:

Taylor Barr [email protected]
Ray Rich [email protected]

The GreenRush Financial Conferences are 100% owned by Next Gen Metals Inc. (CSE:N). Next Gen focuses on investing in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors, and is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Genâ€™s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

Next Gen recently announced a non-brokered private placement of up to 3,000,000 units at $0.10 per unit, for gross proceeds of up to $300,000. For more information about Next Gen, please visit www.nextgenmetalsinc.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals,

specializes in producing short three minute videos based on significant news releases and research reports. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
[email protected]

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: #smallcapstocks, $TSXV, CSE, GreenRush Conferences, GreenRush Financial Conferences, medical Marijuana
Posted in Medical Marijuana Stocks, Next Gen | Comments Off on InvestmentPitch Media Attending Next Gen Metal’s GreenRush Financial Conference in Seattle, Washington on September 23, 2014, Covering Medical Marijuana, Industrial Hemp and Alternative Medicines

Toronto opens first referral-only medical marijuana clinic

Posted by AGORACOM-JC at 11:26 AM on Monday, July 21st, 2014

BLAKE WOLFE | QMI AGENCY

TORONTO – Inside a brand-new medical clinic near the intersection of Yonge St. and Eglinton Ave., a patient walks up to the counter following his appointment.

An employee stands with him, offering advice on the man’s new medication.

“Be sure to grind it well before putting consuming it,” the staffer says. “You want it fluffy like dryer lint. Fluffy is your friend when it comes to vaporizers.”

The patient thanks him for the advice and heads out the door.

It’s a normal exchange at the Cannabinoid Medical Clinic — CMClinic for short — Toronto’s first referral-only medical marijuana clinic.

It was a busy first week for executive director Dr. Danial Schecter and his staff after officially opening the clinic’s doors on July 14 and seeing dozens of the approximately 700 patients on the wait list. Talk of additional clinics in Canada is already taking place, Schecter says.

The clinic opened in the wake of new federal regulations regarding medical marijuana use. The rules, which came into effect on April 1, require that patients procure their stash from an approved supplier with a doctor’s prescription.

Schecter, who learned of marijuana’s medical effects while studying at the University of Montreal, set up the Toronto clinic after successfully using the plant to treat several patients at his former practice near Georgian Bay.

“I had a patient who suffered from anxiety so badly that he literally flapped when he walked into my office,” recalled Schecter, adding that the man self-medicated with alcohol and was afraid to consume marijuana for fear of returning to prison. “I saw his treatment as a success, and when the new regulations were announced, it was an opportunity to help many more people.”

Despite criticism from some doctors and health organizations about the lack of evidence for marijuana’s medical benefits, Schecter said he hopes to change that perception by contributing to the emerging field through his work at the clinic. He explained that in his experience, family doctors fall into three categories:

The 10% who are firmly opposed to the medical use of weed, another 10% who are open to the concept but cautious, and the 80% who are willing to prescribe it as a last resort for patients who have tried everything else.

“This is something that’s talked about for maybe five or 10 minutes in medical school,” Schecter mused. “The research done here will allow us to make a solid contribution to a novel field of medicine. I’m trying to educate the skeptical physicians and help that 80% (willing to prescribe marijuana).”

While other marijuana clinics have recently sprung up in Toronto, Schecter is quick to point out that CMClinic is referral-only and is covered through OHIP, similar to other medical specialists that a patient may be referred to by their family doctor.

Clinic spokesman Bridget Best said the facility operates more as a referral and educational centre for doctors and patients who may need assistance in learning about the various forms that cannabis can take as well as the myriad consumption methods.

Schecter said that as opposed to the typical recreational user who may consume mass quantities of weed due to tolerance of the drug, his patients often manage their pain by using less than a gram per day.

While patients are free to consume marijuana in whichever way they choose, the clinic sells vaporizers (which create marijuana vapour instead of smoke) as opposed to typical head shop fare like glass pipes and bongs.

No marijuana is stored on site, Best said.

Pursuing a medication more often associated with recreational and illicit consumption is often a last resort for most of the clinic’s patients — many of whom hail from various points across the GTA and southern Ontario, while others still have inquired from as far away as Germany and Panama.

Schecter, who said that he tries to avoid prescribing pot to anyone under 25 due to the inconclusive effects of the drug on the growing brain, deals predominantly with patients in “chronic pain,” ranging from those suffering with the lingering effects of accidents and chemotherapy to those requiring palliative care.

Travelling to the clinic from Bowmanville, patient Bob Landry recalled the 2011 traffic accident that left him with lingering pain and headaches. While Landry said that he has successfully used marijuana to treat his condition after traditional prescription drugs proved either ineffective or unthinkable, he sought out the clinic to help with proper dosages.

“I tried normal painkillers first, then my doctor offered me Oxycontin — I refused,” Landry said, explaining that his cousin had died from the controversial drug. “I believe this is the solution. I prefer to acquire it legally and, this way, I know what I’m getting.

“I hope to one day return to my normal activities.”

Source: http://www.sunnewsnetwork.ca/sunnews/canada/archives/2014/07/20140720-162102.html

Tags: #smallcapstocks, $TSXV, CSE, medical Marijuana
Posted in Enertopia Corp., Lexaria Corp., Medical Marijuana Stocks, Next Gen | Comments Off on Toronto opens first referral-only medical marijuana clinic

Archive for the ‘Medical Marijuana Stocks’ Category

Categories